Kezdőlap・Részvénylista・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Lezárt

SzektorEgészségügy

575.5 -0.21

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

562.67

Maximum

577.21

Fő mutatók
By Trading Economics
Bevétel	85M 1.7B
Értékesítés	989M 12B
P/E Szektor átlag	30.575 64.641
Egy részvényre jutó nyereség	6.03
Osztalékhozam	0.15
Profit margin	14.516
Munkavállalók	125,000
EBITDA	262M 2.6B

Ajánlások
By TipRanks
Ajánlások	Vétel
12 hónapos előrejelzés	+6.98% upside

Osztalékok
By Acuity
Osztalékhozam Szektor átlag	0.15% 2.31%
Következő eredményjelentés	2026. okt. 21.
Következő osztalékfizetési dátum	2026. okt. 15.
Következő korábbi osztalék dátum	2026. szept. 15.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	17B 213B
Előző nyitás	575.71
Előző zárás	575.5

Hangulat hírek alapján

By Acuity

23%

77%

66 / 340 Rangsor szerint Healthcare

Thermo Fisher Scientific Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. júl. 31. 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

2026. júl. 30. 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

2026. júl. 29. 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

2026. júl. 28. 18:06 UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

2026. júl. 27. 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

2026. júl. 24. 19:23 UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

2026. júl. 23. 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

2026. júl. 22. 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

2026. júl. 21. 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

2026. júl. 20. 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Társak összehasonlítása

Árváltozás

Thermo Fisher Scientific Inc Előrejelzés

Célár

By TipRanks

6.98% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 614.41 USD 6.98%

Magas 690 USD

Alacsony 520 USD

19 Wall Street elemző 12 hónapos célárain alapulva a(z)Thermo Fisher Scientific Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

19 ratings

Vétel

Tartás

Eladás

19 Wall Street elemző célárain alapulva a(z)Thermo Fisher Scientific Inc termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

66 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar